694 related articles for article (PubMed ID: 33372854)
1. SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species.
Moustaqil M; Ollivier E; Chiu HP; Van Tol S; Rudolffi-Soto P; Stevens C; Bhumkar A; Hunter DJB; Freiberg AN; Jacques D; Lee B; Sierecki E; Gambin Y
Emerg Microbes Infect; 2021 Dec; 10(1):178-195. PubMed ID: 33372854
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 nsp5 Exhibits Stronger Catalytic Activity and Interferon Antagonism than Its SARS-CoV Ortholog.
Chen J; Li Z; Guo J; Xu S; Zhou J; Chen Q; Tong X; Wang D; Peng G; Fang L; Xiao S
J Virol; 2022 Apr; 96(8):e0003722. PubMed ID: 35389264
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3.
Fung SY; Siu KL; Lin H; Yeung ML; Jin DY
Int J Biol Sci; 2021; 17(6):1547-1554. PubMed ID: 33907518
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response.
Liu Y; Qin C; Rao Y; Ngo C; Feng JJ; Zhao J; Zhang S; Wang TY; Carriere J; Savas AC; Zarinfar M; Rice S; Yang H; Yuan W; Camarero JA; Yu J; Chen XS; Zhang C; Feng P
mBio; 2021 Oct; 12(5):e0233521. PubMed ID: 34544279
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic processing, deubiquitinase and interferon antagonist activities of Middle East respiratory syndrome coronavirus papain-like protease.
Yang X; Chen X; Bian G; Tu J; Xing Y; Wang Y; Chen Z
J Gen Virol; 2014 Mar; 95(Pt 3):614-626. PubMed ID: 24362959
[TBL] [Abstract][Full Text] [Related]
6. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity.
Shin D; Mukherjee R; Grewe D; Bojkova D; Baek K; Bhattacharya A; Schulz L; Widera M; Mehdipour AR; Tascher G; Geurink PP; Wilhelm A; van der Heden van Noort GJ; Ovaa H; Müller S; Knobeloch KP; Rajalingam K; Schulman BA; Cinatl J; Hummer G; Ciesek S; Dikic I
Nature; 2020 Nov; 587(7835):657-662. PubMed ID: 32726803
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 main protease cleaves MAGED2 to antagonize host antiviral defense.
Ju X; Wang Z; Wang P; Ren W; Yu Y; Yu Y; Yuan B; Song J; Zhang X; Zhang Y; Xu C; Tian B; Shi Y; Zhang R; Ding Q
mBio; 2023 Aug; 14(4):e0137323. PubMed ID: 37439567
[TBL] [Abstract][Full Text] [Related]
8. Proteolytic cleavage and inactivation of the TRMT1 tRNA modification enzyme by SARS-CoV-2 main protease.
Zhang K; Eldin P; Ciesla JH; Briant L; Lentini JM; Ramos J; Cobb J; Munger J; Fu D
Elife; 2024 May; 12():. PubMed ID: 38814682
[TBL] [Abstract][Full Text] [Related]
9. Aloin isoforms (A and B) selectively inhibits proteolytic and deubiquitinating activity of papain like protease (PLpro) of SARS-CoV-2 in vitro.
Lewis DSM; Ho J; Wills S; Kawall A; Sharma A; Chavada K; Ebert MCCJC; Evoli S; Singh A; Rayalam S; Mody V; Taval S
Sci Rep; 2022 Feb; 12(1):2145. PubMed ID: 35140265
[TBL] [Abstract][Full Text] [Related]
10. Predicted coronavirus Nsp5 protease cleavage sites in the human proteome.
Scott BM; Lacasse V; Blom DG; Tonner PD; Blom NS
BMC Genom Data; 2022 Apr; 23(1):25. PubMed ID: 35379171
[TBL] [Abstract][Full Text] [Related]
11. Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity.
Harcourt BH; Jukneliene D; Kanjanahaluethai A; Bechill J; Severson KM; Smith CM; Rota PA; Baker SC
J Virol; 2004 Dec; 78(24):13600-12. PubMed ID: 15564471
[TBL] [Abstract][Full Text] [Related]
12. A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease.
Patchett S; Lv Z; Rut W; Békés M; Drag M; Olsen SK; Huang TT
Cell Rep; 2021 Sep; 36(13):109754. PubMed ID: 34547223
[TBL] [Abstract][Full Text] [Related]
13. Ciclesonide Inhibits SARS-CoV-2 Papain-Like Protease in Vitro.
Kiba Y; Tanikawa T; Kitamura M
Biol Pharm Bull; 2024; 47(5):965-966. PubMed ID: 38763750
[TBL] [Abstract][Full Text] [Related]
14. Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease.
Miczi M; Golda M; Kunkli B; Nagy T; Tőzsér J; Mótyán JA
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333742
[TBL] [Abstract][Full Text] [Related]
15. Comparative Host Interactomes of the SARS-CoV-2 Nonstructural Protein 3 and Human Coronavirus Homologs.
Almasy KM; Davies JP; Plate L
Mol Cell Proteomics; 2021; 20():100120. PubMed ID: 34186245
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 3C-like protease antagonizes interferon-beta production by facilitating the degradation of IRF3.
Zhang W; Ma Z; Wu Y; Shi X; Zhang Y; Zhang M; Zhang M; Wang L; Liu W
Cytokine; 2021 Dec; 148():155697. PubMed ID: 34509038
[TBL] [Abstract][Full Text] [Related]
17. Porcine Deltacoronavirus nsp5 Cleaves DCP1A To Decrease Its Antiviral Activity.
Zhu X; Chen J; Tian L; Zhou Y; Xu S; Long S; Wang D; Fang L; Xiao S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32461317
[TBL] [Abstract][Full Text] [Related]
18. Targeting novel structural and functional features of coronavirus protease nsp5 (3CL
Roe MK; Junod NA; Young AR; Beachboard DC; Stobart CC
J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33507143
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Nsp5 Activates NF-κB Pathway by Upregulating SUMOylation of MAVS.
Li W; Qiao J; You Q; Zong S; Peng Q; Liu Y; Hu S; Liu W; Li S; Shu X; Sun B
Front Immunol; 2021; 12():750969. PubMed ID: 34858407
[TBL] [Abstract][Full Text] [Related]
20. Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS-COV-2 targeting main protease and papain-like protease.
Choudhary S; Nehul S; Singh A; Panda PK; Kumar P; Sharma GK; Tomar S
IUBMB Life; 2024 May; 76(5):228-241. PubMed ID: 38059400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
